Shilpa Medicare executes transfer agreement with Shilpa Pharma Lifesciences

04 Jul 2022 Evaluate

Shilpa Medicare has executed business transfer agreement with Shilpa Pharma Lifesciences (Formerly known as Shilpa Corporate Holdings) the transferee company which is complete and effective from June 30, 2022. With effect from closing of the transaction, Shilpa Pharma Lifesciences, a wholly owned subsidiary of Shilpa Medicare shall operate the API (Active Pharmaceutical Ingredient) business.

Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.

Shilpa Medicare Share Price

309.55 9.35 (3.11%)
04-Feb-2026 10:58 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1699.00
Dr. Reddys Lab 1241.30
Cipla 1333.90
Zydus Lifesciences 904.50
Lupin 2176.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×